Search results
Showing 616 to 630 of 726 results for innovative
This guideline covers how to increase uptake of the free flu vaccination among people who are eligible. It describes ways to increase awareness and how to use all opportunities in primary and secondary care to identify people who should be encouraged to have the vaccination.
This document describes a real-world evidence framework that aims to improve the quality of real-world evidence informing our guidance. The framework does not set minimum standards for the acceptability of evidence. The framework is mainly targeted at those developing evidence to inform NICE guidance. It is also relevant to patients, those collecting data, and reviewers of evidence
This manual explains how NICE develops and updates social care guidance. It provides advice on the technical aspects of guidance development and the methods used
First HIV prevention injection for people unable to have daily PrEP recommended
A ground-breaking HIV-1 prevention injection has been recommended by NICE, marking a significant advance for a small group of adults and young people unable to have daily pre-exposure prophylaxis (PrEP) tablets.
Interim methods guide for developing good practice guidance (PMG15)
This interim methods guide is based on the general principles and methods included in other methods guides for developing NICE guidance
Methods for the development of NICE public health guidance (third edition) (PMG4)
This manual describes the methods used by the Centre for Public Health Excellence (CPHE) in NICE to develop and update public health guidance
We explore the ongoing debate around NICE’s cost-effectiveness thresholds and what the future holds.
Biographies and registered interests for members of the Technology Appraisal Committee C
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
NICE has a key role in UK licensing and the evaluation of and access to new and innovative products for the health system.
Biographies and registered interests for members of the Technology Appraisal Committee A
NICE's guidance executive is made up of executive directors, guidance centre directors and senior team members.
Day-to-day decision making is the responsibility of NICE's executive team.
A new model for evaluating and purchasing antimicrobials in the UK
Overview of NICE and NHS England’s pioneering subscription-style purchasing model for antimicrobials: its pilot with ceftazidime-avibactam and cefiderocol in 2022, expansion in 2024, supporting health technology assessments, downloadable guidance and procurement tools.
A joint NICE and NHS England meeting can help to ensure you're ready for NHS patient access and subsequent NICE appraisal